Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01853670 · ClinicalTrials.gov registry record · NA

Adaptive Radiation Therapy for Head & Neck Cancer Patients

A NA study of Cancer of Head and Neck, sponsored by Beth Israel Medical Center.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT01853670 is a NA study of Cancer of Head and Neck that has completed, run by Beth Israel Medical Center. The registered enrollment target is 6 participants, below the 249-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01853670, a NA study of Cancer of Head and Neck, has completed, sponsored by Beth Israel Medical Center.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT imaging to track the dose delivered in head and neck cancer patients, to assess the benefit of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on kV cone beam CT compare to the standard approach (orthogonal pair), and to develop remote access tools (preferably internet-based) so that the MD can approve these plans in real time.

Conditions Studied

Interventions

  • RADIATION concurrent chemo + IGRT
  • RADIATION neoadjuvant chemo + IGRT

Study Locations (1)

New York

  • Beth Israel Medical Center - New York

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2009-08
Est. Completion 2015-01
Phase NA

Sponsor

Beth Israel Medical Center

44 total trials

What the Registry Record Tells You About NCT01853670

The ClinicalTrials.gov registry entry for NCT01853670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 249-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (98% lower). The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer of Head and Neck appearing as the primary indexed condition, and to 2 interventions - of which concurrent chemo + IGRT is the first listed.

NCT01853670 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01853670 about?

NCT01853670 is a clinical study titled "Adaptive Radiation Therapy for Head & Neck Cancer Patients". The purpose of this study is to determine the utility of kilovoltage (kV) cone beam CT imaging to track the dose delivered in head and neck cancer patients, to assess the benefit of cone beam CT to patients set-up for radiation treatment, to determine how shifts based on kV cone beam CT compare to t...

What is the current status of trial NCT01853670?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2009-08. Estimated completion is 2015-01.

What conditions does trial NCT01853670 study?

This clinical trial studies the following conditions: Cancer of Head and Neck.

What interventions are being tested in trial NCT01853670?

The interventions under investigation include: concurrent chemo + IGRT (RADIATION), neoadjuvant chemo + IGRT (RADIATION).

Who is sponsoring clinical trial NCT01853670?

This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01853670 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer of Head and Neck

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.